181 related articles for article (PubMed ID: 33574667)
1. Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions.
Tzeng WS; Teng WL; Huang PH; Lin TC; Yen FL; Shiue YL
Int J Nanomedicine; 2021; 16():867-879. PubMed ID: 33574667
[TBL] [Abstract][Full Text] [Related]
2. Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration.
Huang PH; Hu SC; Lee CW; Yeh AC; Tseng CH; Yen FL
Int J Nanomedicine; 2016; 11():1615-27. PubMed ID: 27143883
[TBL] [Abstract][Full Text] [Related]
3. Poly(lactic-
Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
[TBL] [Abstract][Full Text] [Related]
4. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
Ma P; Chen J; Qu H; Li Y; Li X; Tang X; Song Z; Xin H; Zhang J; Nai J; Li Z; Wang Z
Drug Deliv; 2020 Dec; 27(1):1412-1424. PubMed ID: 33096947
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
[TBL] [Abstract][Full Text] [Related]
7. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
Yin W; Xu J; Li C; Dai X; Wu T; Wen J
Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
[TBL] [Abstract][Full Text] [Related]
8. Enhanced autophagic activity of artocarpin in human hepatocellular carcinoma cells through improving its solubility by a nanoparticle system.
Tzeng CW; Tzeng WS; Lin LT; Lee CW; Yen FL; Lin CC
Phytomedicine; 2016 May; 23(5):528-40. PubMed ID: 27064012
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia as a target for drug combination therapy of liver cancer.
Bowyer C; Lewis AL; Lloyd AW; Phillips GJ; Macfarlane WM
Anticancer Drugs; 2017 Aug; 28(7):771-780. PubMed ID: 28542038
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits.
Zhang X; Dai F; Chen J; Xie X; Xu H; Bai C; Qiao W; Shen W
Cancer Biol Ther; 2019; 20(5):642-652. PubMed ID: 30621501
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Migration and Invasion of Hepatocarcinoma HepG2 Cells by Dietary Saponins via Targeting HIF-1α.
Luo C; Wu D; Chen M; Miao W; Xue C; Sun Y; Liu D; Xie C; Wang Y; Frenz C; Deng S
Anticancer Agents Med Chem; 2018; 18(7):1025-1031. PubMed ID: 29318977
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
Liu KG; Xie HH; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
[TBL] [Abstract][Full Text] [Related]
13. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition.
Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G
Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022
[TBL] [Abstract][Full Text] [Related]
14. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells.
Tak E; Jun DY; Kim SH; Park GC; Lee J; Hwang S; Song GW; Lee SG
J Int Med Res; 2016 Dec; 44(6):1234-1247. PubMed ID: 27807254
[TBL] [Abstract][Full Text] [Related]
17. Extracts of Celastrus Orbiculatus Inhibit Cancer Metastasis by Down-regulating Epithelial-Mesenchymal Transition in Hypoxia-Induced Human Hepatocellular Carcinoma Cells.
Qian YY; Shi YY; Lu SH; Yang T; Zhao XY; Yan Y; Li WY; Liu YQ
Chin J Integr Med; 2019 May; 25(5):334-341. PubMed ID: 30046956
[TBL] [Abstract][Full Text] [Related]
18. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
19. Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1α.
Wang BF; Wang XJ; Kang HF; Bai MH; Guan HT; Wang ZW; Zan Y; Song LQ; Min WL; Lin S; Cheng YA
Cell Physiol Biochem; 2014; 33(1):37-51. PubMed ID: 24401554
[TBL] [Abstract][Full Text] [Related]
20. Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway.
Yang X; Gao M; Miao M; Jiang C; Zhang D; Yin Z; Ni Y; Chen J; Zhang J
J Pharm Pharmacol; 2021 Mar; 73(2):263-271. PubMed ID: 33793802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
